The Department of Translational Hematology & Oncology Research conducts cancer research to develop and make available novel diagnostic tools, targeted therapies and clinical trials for direct use in patient care.More About Us
Preliminary research shows that drugs used to treat blood and neurological disorders can be repurposed to treat chemorefractory lung cancer.
Work with computer and preclinical models aims to bridge the gap between studying evolutionary biology in the lab and delivering to patient care.
Precision cancer medicine is the goal of a new multidisciplinary study, led by Dr. Tim Chan, examining radiation therapy combined with targeted therapy
Exciting investigation and groundbreaking discovery happens every day at Cleveland Clinic. Join our team of expert researchers at the Department of Translational Hematology & Oncology Research.View Careers